FDA inspection
CTX Lifesciences Private Ltd.: FDA inspection ending Feb 16, 2019
FDA inspection 1081201 · Official Action Indicated (OAI) · Surat
Key facts
| Inspection ID | 1081201 |
|---|---|
| Firm | CTX Lifesciences Private Ltd. |
| FEI number | 3006254924 |
| Address | 251 - 252 Plot, Sachin Magdalla Highway |
| City | Surat |
| Fiscal year | 2019 |
| Inspection end date | Feb 16, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 577416 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data